Preprint Review Version 2 Preserved in Portico This version is not peer-reviewed

Physical Bases of Boron Neutron Capture Therapy, Dosimetry, and Its Mechanisms of Action—A Critical Overview of the Literature

Version 1 : Received: 24 September 2021 / Approved: 27 September 2021 / Online: 27 September 2021 (15:07:48 CEST)
Version 2 : Received: 8 November 2021 / Approved: 10 November 2021 / Online: 10 November 2021 (14:29:43 CET)
Version 3 : Received: 16 May 2022 / Approved: 16 May 2022 / Online: 16 May 2022 (15:22:13 CEST)

A peer-reviewed article of this Preprint also exists.

Skwierawska, D., López-Valverde, J. A., Balcerzyk, M., & Leal, A. (2022). Clinical Viability of Boron Neutron Capture Therapy for Personalized Radiation Treatment. Cancers, 14(12), 2865. Skwierawska, D., López-Valverde, J. A., Balcerzyk, M., & Leal, A. (2022). Clinical Viability of Boron Neutron Capture Therapy for Personalized Radiation Treatment. Cancers, 14(12), 2865.

Abstract

The success of boron neutron capture therapy (BNCT) depends mainly on sufficient spatial biodistribution of boron (B-10) localized around or within neoplastic cells to produce a high dose gradient between the tumor and healthy tissue. Contrary to what is usual in radiotherapy, BNCT proposes treatment planning directed at the cell rather than the tumor mass. However, it is not yet possible to precisely determine the concentration of B-10 in a specific tissue in real-time using non-invasive methods. Some critical issues still need to be resolved if BNCT is to become a valuable, minimally invasive, and efficient cancer treatment. This review article provides an overview of the funda-mental principles, recent advances, and future directions of BNCT as a cell-targeted cancer therapy. The main emphasis is on topics related to biological dosimetry, methods for assessing boron concentration, mechanisms of action of BNCT, and its physical bases for clinical implementation.

Keywords

boron neutron capture therapy (BNCT); boron imaging; biological dosimetry; radiation therapy

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.